We are live on ! Find out more
LP

Longaeva Partners Portfolio holdings

AUM $2.7B
1-Year Est. Return 37.16%
This Fund
S&P 500
This Quarter Est. Return
-3.4%
1 Year Est. Return
+37.16%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$2.7B
AUM Growth
+$1.51B
Cap. Flow
+$1.75B
Cap. Flow %
64.98%
Top 10 Hldgs %
35.87%
Holding
269
New
150
Increased
33
Reduced
19
Closed
65

Top Buys

Rank Stock Value
1
BAC icon
Bank of America
BAC
+$80.3M
2
BSX icon
Boston Scientific
BSX
+$76.6M
3
KEY icon
KeyCorp
KEY
+$62.3M
4
GS icon
Goldman Sachs
GS
+$60.3M
5
MMED
MiniMed Group Inc
MMED
+$52.4M

Top Sells

Rank Stock Value
1
CAI
Caris Life Sciences
CAI
+$40.7M
2
BDX icon
Becton Dickinson
BDX
+$25.5M
3
TPG icon
TPG
TPG
+$23.9M
4
NVO
Novo Nordisk
NVO
+$22.6M
5
EW icon
Edwards Lifesciences
EW
+$22.1M

Sector Composition

Rank Sector Weight
1 Financials 31.18%
2 Healthcare 16.78%
3 Technology 12.09%
4 Industrials 6.84%
5 Consumer Discretionary 6.29%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ASML icon
26
ASML
ASML
$675B
$26M 0.96%
+19,653
New +$26.9M
TOST icon
27
Toast
TOST
$16.8B
$24.9M 0.92%
941,001
+600,076
+176% +$17.9M
WEX icon
28
WEX
WEX
$6.11B
$24.7M 0.91%
+161,275
New +$25.2M
AMZN icon
29
Amazon
AMZN
$2.5T
$24M 0.89%
115,351
+41,851
+57% +$9.21M
NRIX icon
30
Nurix Therapeutics
NRIX
$2.43B
$23.1M 0.86%
1,490,202
+562,473
+61% +$9.33M
AS icon
31
Amer Sports
AS
$19.7B
$23M 0.85%
698,513
+248,185
+55% +$9.07M
PJT icon
32
PJT Partners
PJT
$4.37B
$21.7M 0.8%
+154,987
New +$24.4M
SBUX icon
33
Starbucks
SBUX
$118B
$21M 0.78%
+233,870
New +$22.1M
C icon
34
Citigroup
C
$222B
$20.5M 0.76%
180,620
+52,306
+41% +$5.96M
BEN icon
35
Franklin Resources
BEN
$16.9B
$20.4M 0.75%
862,737
+300,473
+53% +$7.73M
JKHY icon
36
Jack Henry & Associates
JKHY
$10.7B
$20.2M 0.75%
+128,056
New +$21.9M
JCI icon
37
Johnson Controls International
JCI
$87.5B
$19.5M 0.72%
+149,002
New +$19.2M
FTRE icon
38
Fortrea Holdings
FTRE
$1.85B
$19.3M 0.71%
2,046,727
+1,794,653
+712% +$23.1M
GENI icon
39
CALL
Genius Sports
GENI
$1.73B
$18.4M 0.68%
4,153,400
+2,233,400
+116% +$15.9M
RELY icon
40
Remitly
RELY
$4.74B
$17.6M 0.65%
1,123,723
+826,034
+277% +$12.2M
NVDA icon
41
NVIDIA
NVDA
$5.01T
$17.1M 0.63%
+98,128
New +$18M
GENI icon
42
Genius Sports
GENI
$1.73B
$17M 0.63%
3,841,145
+1,554,561
+68% +$11.1M
META icon
43
Meta Platforms (Facebook)
META
$1.51T
$16.8M 0.62%
+29,436
New +$18.9M
AAL icon
44
CALL
American Airlines Group
AAL
$9.58B
$16.6M 0.62%
+1,550,000
New +$20.5M
AMAT icon
45
Applied Materials
AMAT
$426B
$16.6M 0.62%
+48,642
New +$16.4M
NVT icon
46
nVent Electric
NVT
$24.5B
$16.6M 0.61%
+140,238
New +$15.9M
PIPR icon
47
Piper Sandler
PIPR
$5.14B
$16.2M 0.6%
+211,601
New +$17.4M
ROST icon
48
Ross Stores
ROST
$76.6B
$16M 0.59%
73,767
-23,000
-24% -$4.58M
AZN icon
49
AstraZeneca
AZN
$263B
$15.8M 0.59%
+80,130
New +$15.5M
PFE icon
50
Pfizer
PFE
$140B
$15.7M 0.58%
+560,615
New +$14.9M

Similar funds

Longaeva Partners's Q1 2026 Portfolio in Review

As of Q1 2026, Longaeva Partners held 269 positions worth $2.7B, up 127% from $1.19B the previous quarter. Its ten largest holdings account for 36% of the portfolio.

Longaeva Partners deployed $1.75B of net new capital in Q1 2026, opening 150 new positions and adding to 33 existing holdings. Its largest new stake was Bank of America: 1,555,661 shares worth $75.8M.

By sector, the portfolio is most concentrated in Financials at 31% of assets, up from 22% a quarter earlier, followed by Healthcare and Technology.

On the sell side, the largest reduction was Annexon, an estimated $14M trimmed.

  • Longaeva Partners's largest Q1 2026 buy was Bank of America: 1,555,661 shares worth $75.8M.
  • Longaeva Partners added most to PNC Financial Services in Q1 2026, an estimated $48M increase.
  • Longaeva Partners's biggest Q1 2026 reduction was Annexon, cutting an estimated $14M.
  • Longaeva Partners fully exited Caris Life Sciences in Q1 2026, selling an estimated $40.7M.
  • Longaeva Partners's ten largest holdings make up 36% of its $2.7B portfolio in Q1 2026.
  • Longaeva Partners opened 150 new positions and closed 65 in Q1 2026.
  • Longaeva Partners's portfolio value rose 127% quarter-over-quarter to $2.7B.

Based on Longaeva Partners's 13F filing for Q1 2026, filed 15 May 2026.